Skip to content

Clinical trials

Phase 3 Pulmonary Disease, Chronic Obstructive trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Phase 3 Country / region: United States Clear all

223 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20013
20029
20036
20043
20056
20069
20077
20089
200922
201011
201118
201216
201315
201415
201513
20166
20175
20184
20193
20206
20214
20227
20235
20245
20257
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed188
Recruiting14
Terminated14
Unknown status4
Active, not recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline42
Boehringer Ingelheim35
AstraZeneca33
Novartis Pharmaceuticals17
Pearl Therapeutics, Inc.12
Novartis8
Sanofi8
Sumitomo Pharma America, Inc.8
Dey6
Mylan Inc.5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive223
Emphysema17
Bronchitis, Chronic16
Lung Diseases9
Lung Diseases, Obstructive6
Respiratory Tract Diseases6
Asthma4
Diabetes Mellitus3
Bronchial Diseases2
Bronchitis2

Trials

Showing 1 to 25 of 223. Each trial links to its page on Pharma Observatory.

123 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.